Construction of the factory for production of Chinese vaccine in Zemun has begun - Completion in the first quarter of 2022

The construction of a factory for the production of vaccines by the Chinese company Sinopharm, a joint investment by Serbia, China and the United Arab Emirates, worth EUR 30 million, has begun in the Zemun neighborhood of Soko Salas, the Government of Serbia has announced.

The new factory, which will cover 11,800 m2 in its initial phase, will produce about 30 million vaccines a year, and will have the capacity to produce 40 million vaccines.

The plan is for the factory to be completed in the first quarter of next year, until when the filling of the Sinopharm vaccine will be done in Hemofarm.

The cornerstone, together with the President of Serbia Aleksandar Vucic, was laid by the Chinese Ambassador to Serbia Chen Bo, the General and Executive Director of Mubadala and a member of the Management Board of Group 42 Kaldun Al Mubarak and the General Director of Group 42 Peng Xiao.

Vucic stated that the first facility, where the Chinese vaccines are to be loaded, will be completed by the end of March next year, and in the second phase, by 2023, also the facility for the production of active substance for the vaccine.

- In the initial phase, 180 people will work in the factory, out of which 40% will be highly qualified staff, and in the second phase, additional 100 workers will be employed - said Vucic.

Predsedništvo Republike Srbije

Ambasada NR Kine Beograd

Hemofarm a.d. Vršac

Mubadals

Group 42

Aleksandar Vucic

Chen Bo

Kaldun Al Mubarak

Peng Xiao

Sinopharm

vaccine factory

Chinese vaccines

factory for production of Chinese vaccine

construction of Sinopharm factory